company background image
A174900 logo

AbClon KOSDAQ:A174900 Stock Report

Last Price

₩15.62k

Market Cap

₩268.9b

7D

6.3%

1Y

-5.8%

Updated

21 Jul, 2024

Data

Company Financials

A174900 Stock Overview

Engages in the research and development of antibody drugs in South Korea and Sweden.

A174900 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

AbClon Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for AbClon
Historical stock prices
Current Share Price₩15,620.00
52 Week High₩22,150.00
52 Week Low₩10,950.00
Beta0.16
11 Month Change-3.58%
3 Month Change-0.83%
1 Year Change-5.85%
33 Year Change-28.68%
5 Year Change-27.94%
Change since IPO20.15%

Recent News & Updates

Is AbClon (KOSDAQ:174900) A Risky Investment?

Apr 23
Is AbClon (KOSDAQ:174900) A Risky Investment?

Recent updates

Is AbClon (KOSDAQ:174900) A Risky Investment?

Apr 23
Is AbClon (KOSDAQ:174900) A Risky Investment?

Does AbClon (KOSDAQ:174900) Have A Healthy Balance Sheet?

Feb 16
Does AbClon (KOSDAQ:174900) Have A Healthy Balance Sheet?

The AbClon (KOSDAQ:174900) Share Price Is Up 85% And Shareholders Are Holding On

Dec 25
The AbClon (KOSDAQ:174900) Share Price Is Up 85% And Shareholders Are Holding On

Shareholder Returns

A174900KR BiotechsKR Market
7D6.3%-0.5%-2.1%
1Y-5.8%25.7%4.3%

Return vs Industry: A174900 underperformed the KR Biotechs industry which returned 25.7% over the past year.

Return vs Market: A174900 underperformed the KR Market which returned 4.3% over the past year.

Price Volatility

Is A174900's price volatile compared to industry and market?
A174900 volatility
A174900 Average Weekly Movement7.5%
Biotechs Industry Average Movement8.0%
Market Average Movement4.9%
10% most volatile stocks in KR Market11.1%
10% least volatile stocks in KR Market2.2%

Stable Share Price: A174900's share price has been volatile over the past 3 months.

Volatility Over Time: A174900's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2010n/an/awww.abclon.com

AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. The company’s products in pipeline include NEST platform technology products for breast and gastric cancers; AffiMab platform technology products for colon cancer and autoimmune diseases; and CAR-T platform technology products for hematologic and ovarian cancers. AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.

AbClon Inc. Fundamentals Summary

How do AbClon's earnings and revenue compare to its market cap?
A174900 fundamental statistics
Market cap₩268.95b
Earnings (TTM)-₩16.34b
Revenue (TTM)₩2.64b

101.7x

P/S Ratio

-16.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A174900 income statement (TTM)
Revenue₩2.64b
Cost of Revenue₩635.30m
Gross Profit₩2.01b
Other Expenses₩18.35b
Earnings-₩16.34b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-949.03
Gross Margin75.97%
Net Profit Margin-618.20%
Debt/Equity Ratio59.0%

How did A174900 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.